The APN is a national system of research facilities and expertise, delivering infrastructure enabling biomedical discovery and translation.
Phenomics provides the tools and animal models to support the large-scale, systematic study of gene function. The phenomics approach seeks to help clinicians to discover gene function, to determine the genetic causes of disease, and to deliver more tailored medicine for individuals. The era of precision medicine is dawning, and promises to transform society. The APN suite of cutting edge technologies and expertise is helping Australia’s scientists remain at the forefront of discovery and translation.
We are very pleased to be joining the 10th Annual Functional High Throughput Technologies Australia (FHTTA) meeting, being held at the John Curtin School of Medical Research, Australian National University, Canberra. For more information and to register your attendance, visit the event website through the link above.
ENABLING GENOMIC MEDICINE
Australia has considerable ambitions in Genomic Medicine. The Genomics Health Futures Mission is the centrepiece of the Australian Government’s $1.3 billion National Health and Medical Industry Growth Plan, seeking to transform Australian healthcare through genomics and precision medicine. Functional genomics and phenomics will be centre stage to deliver on these ambitions.
The Australian Phenomics Network provides an extensive portfolio of integrated and forward-thinking infrastructure platforms to drive fundamental Genomic Medicine research and achieve these important healthcare outcomes.
The Australian Phenomics Network enables Genomic Medicine by:
Supporting biomedical researchers and clinicians to discover the genetic drivers of human disease;
Delivering efficient access to the high-quality, cost-effective functional genomics infrastructure for discovery research and Genomic Medicine;
Producing and maintaining model systems, phenotyping capability, and the archiving and distribution of models and data;
Promoting scientific partnerships and collaborations between researchers, clinicians and industry;
Nurturing a skilled workforce; and
Expanding national and international research networks.
The APN was established in 2007 and is one of the founding NCRIS capabilities.
NCRIS supports Australia’s research capability by investing in research infrastructure and making it accessible to researchers across the nation.
NCRIS co-investments through the APN have built and delivered the research infrastructure services necessary to accelerate biomedical discovery and translation. The APN creates, characterises and curates animal models of human disease, enabling new understanding of disease mechanism, leading to therapeutic innovations.